AffaMed Therapeutics Announces Appointment of Vijay Karwal as Chief Financial Officer

SHANGHAI, May 17, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, neurological and psychiatric disorders, today announced the appointment of Vijay Karwal as Chief Financial Officer. Reporting to AffaMed's CEO Dr. Dayao Zhao, Mr. Karwal will be responsible for all aspects of financial management and will work closely with AffaMed's leadership team to support the company's advancement into a leading biopharmaceuticals company.

"We are extremely pleased to have Vijay join AffaMed at this critical juncture in our development," said Dr. Zhao, CEO of AffaMed. "His extensive global experience and track record in executing financial transactions and advising on corporate strategy in both operating and investment banking roles will be invaluable in supporting AffaMed as we enter our next phase of growth. We look forward to welcoming Vijay to the team."

Based in Hong Kong, Mr. Karwal joins AffaMed from Nomura International where he served as Managing Director and Head of Healthcare Investment Banking for the Asia (ex-Japan) region. Prior to Nomura, he was Chief Development Officer, Asia Pacific, as well as General Manager of China operations for DaVita Inc., the international provider of kidney care services. Mr. Karwal previously held several senior investment banking roles globally, including as Asia Pacific Head of Consumer, Retail & Healthcare coverage at RBS, and as Head of Healthcare Banking in North America at ABN AMRO. Throughout his 25-year career he has been involved in a wide variety of advisory and financing transactions in the healthcare sector globally. A native of the Netherlands, Mr. Karwal was educated at the University of Southampton, UK, and the University of Groningen, the Netherlands, holds a M.Sc. in Economics, and is also a CFA charterholder.

Vijay Karwal commented, "Since its inception in 2019, AffaMed has built an exceptional global platform to develop innovative therapeutics and solutions to serve patients in Greater China and worldwide. Under the leadership of Dr. Zhao and with the strong support of its shareholders, the company has assembled world-class capabilities in clinical development, regulatory affairs and business development. Joining AffaMed is an exciting opportunity to work with a highly committed and professional team to deliver transformational medicines addressing significant unmet and under-served needs in patients with ophthalmic, neurological and psychiatric disorders. I look forward to contributing to AffaMed's growth and helping the team advance their strategic and financial objectives."

In March 2021, AffaMed announced the successful completion of over US$170 million in series B financing. The company also recently announced it has entered into an agreement with SIFI S.p.A, a leading international ophthalmic company, to establish a Joint Venture to develop, manufacture and commercialize premium innovative intraocular lenses (IOLs) in the Greater China market, including Taiwan, Macau and Hong Kong.

About AffaMed Therapeutics
AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs in ophthalmic, neurological and psychological disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality clinical development, regulatory affairs, CMC, business development and commercial operations at leading multi-national pharmaceutical companies in China and globally. AffaMed Therapeutics was founded and funded by the CBC Group in 2019.

Tags:
Look out for further updates on our Facebook fan page!

Related Articles

  • 【職場兩性】工作上唔開心同男朋友呻 只獲得冷淡回應 女網民:情侶間報喜不報憂?

    每個人工作都有不開心的時候,偶爾也想與身邊親密的人呻苦,尋求心靈上的安慰。最近有女網民在討論區上分享與男友的相處點滴,表示當她每次呻工作不如意事,對方只會冷淡回應,有時甚至反過來指責她「你一早聽我講就唔使咁啦」,令她情緒更低落,不敢再與另一半談及工作上的事。

  • 【政府工略】郵政署請客戶服務員 月薪$14,715

    香港郵政署每次推出的職位空缺,都吸引到不少求職者目光,如郵政員、助理經理、行政文員、郵品製作員等等,雖然未必每個職位都以公務員條款聘用,可是仍然是熱門空缺。今次郵政局請客戶服務員,月薪$14,715,入職條件不高,有興趣的求職者可於2021年5月20日。

  • 【返工血淚史】落雨返工被淋濕 打工仔︰香港人擔遮真係要考牌!

    香港的夏天潮濕多雨,頻繁的下雨天自然要「一遮傍身」。不過,香港環境狹窄,在本來人多的街道上打開雨傘,經常會出現「相撞」的情況,在上、下班時間情況更為嚴重。

  • 【職場兩性】男友工作加班冇時間陪自己 女友:佢得閒都淨係打機……

    打工仔要返工,加上在加班文化的盛行下,私人時間實在少之又少;有拍拖的打工仔,有時放工後累得,連與另一半溝通都不太想,可能就單純地想休息一下……

  • 【職場熱話】Fresh Grad質疑自己工作能力 食飯嚎哭 網民群起安慰:唔好將就 要有底線!

    很多打工仔都面對很大的工作壓力,而初踏社會的職場新鮮人,由學校到職場的轉變,急促又現實,相信每個人都經歷過這段難熬的時間,大家又記得自己是怎樣撐過來的?

  • 【政府工略】水務署請抄錶員 中四學歷 月薪$14,600

    水務署最近招聘抄錶員,學歷及入職條件不高,月薪$14,600。根據政府的職位晉升階梯,抄錶員升到總抄錶員後,薪金最高可達$40,000,可見這份工的前景不錯。

  • 【網絡熱話】工作壓力太大被醫生勸離職 網民︰唔值得為份工犧牲健康呀!

    香港人工作壓力大已是眾所周知,有些行業甚至需要經常OT,可說是為公司賣命。因此,也有不少打工仔因而衍生一些身體毛病,甚或是精神病,情況值得大家關注。

  • 【行業辛酸】大型蛋糕店員工爆料 時薪40蚊Part Time被要求自己洗冷氣?!

    大部分老闆都希望員工十項全能,最好就是樣樣皆精,可以一個打十個。最近有某間大型連鎖蛋糕店職員,在討論區控訴公司要求Part Time員工兼任冷氣技工,幫手清洗冷氣機,激起員工們憤怒。網民紛紛批評該公司度縮慳皮,更有機會令員工冒著工傷的風險。

  • 【返工血淚史】夏天返工「汗水交纏」 打工仔崩潰︰最噁心係視覺、嗅覺同觸覺一齊Feel到啲汗!

    來到5月中,香港已錄得近33度的高溫,雖然在上班時間時仍未烈日當空,但因氣候濕熱焗促,加上高樓大廈的屏風效應,單是每天早上短短的出門時間,打工仔已熱得汗流浹背。

  • 【政府工略】挑戰做消防處實習生!月薪$10,500 識呢項技能有著數?

    「專上學生暑期實習計劃2021」正式開始,政府各部門均陸續招聘專上學生當實習生,為他們未來的職涯規劃做好準備。在云云實習職位空缺中,消防處的廣告最吸引學生留意,今次為大家介紹消防處暑期實習生「政策」及「危險品法例」兩個空缺,月薪$10,500,聘用期由2021年6月至8月,為期兩個月。